During our morning Analyst meeting today, the team was looking across a variety of asset classes and sectors to identify the current leaders, and those likely to continue tracking higher if the broader stock market rally is for real.
One sector that stood out starkly was Big Pharma.
There are some monster bases in the process of resolving higher here.
One of the common criticisms of technical analysis is that it's all self-fulfilling prophecy.
Its proponents argue that technical analysis doesn't work by understanding underlying supply and demand dynamics.
Rather, it operates on a single dimension, where market events are caused either directly or indirectly by a preceding prediction by technician that it was going to perform a certain way.
An intuitive example of the self-fulfilling prophecy hypothesis (SFP) is the classic technical analysis principle of support and resistance.
Those who favor SFP argue that markets only sell off at resistance and bottom at support because other traders identified these levels and acted according to technical analysis principles.
After all, a self-fulfilling prophecy is defined as a person or a group's expectation for the behavior of another group bringing about the expected behavior.
Within the industry, arguments like these tend to get hyperpolarized and over-divisive. That's not surprising considering there's still a cohort of investors that argues technical analysis is like...
Last night we held our August Mid-month Conference Call. This is when we discuss our tactical view of the market and look for any signs of change in the short-term trend.
Let's go through some of the most important charts to track as this month progresses.
I had a blast chatting about some of my favorite charts and what we’re seeing in crypto, the major averages, small-caps, crude, and a lot more. We covered a lot of ground, hitting on some of the most important market themes right now.
Dividend Aristocrats are easily some of the most desirable investments on Wall Street.
These are the names that have increased dividends for at least 25 years, providing steadily increasing income to long-term-minded shareholders.
As you can imagine, the companies making up this prestigious list are some of the most recognizable brands in the world. Coca-Cola, Walmart, and Johnson & Johnson are just a few of the household names making the cut.
Here at All Star Charts, we like to stay ahead of the curve. That's why we're turning our attention to the future aristocrats.
In an effort to seek out the next generation of the cream-of-the-crop dividend plays, we're curating a list of stocks that have raised their payouts every year for five to nine years.
We call them the Young Aristocrats, and the idea is that these are "stocks that pay you to make money."
Imagine if years of consistent dividend growth and high momentum and relative strength had a baby, leaving you with the best of the emerging dividend giants that are outperforming the averages.
We retired our "Five Bull Market Barometers" in 2020 to make room for a new weekly post that's focused on the three most important charts for the week ahead.
This is that post, so let's jump into this week's edition.
As I scrolled through my currency charts this weekend, the same three-word phrase kept popping to mind: "Can’t be short!"
Whether it’s the Swiss franc, the British pound, or the Thai baht, we can’t be short most global currencies against the US dollar. Not at current levels.
Breadth is improving and our bull market re-born checklist has satisfied two more of its criteria. We are moving off the sidelines and getting more involved, increasing equity exposure in both the Cyclical and Tactical Portfolios and staying in harmony with current leadership trends.